Adrenergic innervation of rat sensory ganglia following proximal or distalpainful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment
Ms. Ramer et Ma. Bisby, Adrenergic innervation of rat sensory ganglia following proximal or distalpainful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment, EUR J NEURO, 11(3), 1999, pp. 837-846
Sympathetic axons invade dorsal root ganglia (DRG) following nerve injury,
and activity in the resulting pericellular axonal 'baskets' may underlie pa
inful sympathetic-sensory coupling. Sympathetic sprouting into the DRG may
be stimulated by nerve growth factor (NGF). To test this hypothesis, we inv
estigated the effect of daily anti-NGF administration an pain and on sprout
ing in the DRG induced by chronic sciatic constriction injury (CCI) or L5 s
pinal nerve ligation (SNL). These models have been shown to differ subtly i
n the onset of pain behaviours and adrenergic sprouting, and we now demonst
rate a fundamental difference in the way sympathetic axons invade the DRG:
after CCI, perivascular noradrenergic collaterals sprouted into the DRG in
a manner dependent upon peripherally derived NGF. In contrast, after SNL, r
egenerating sympathetic axons were diverted towards the DRG from the spinal
nerve by the obstructing ligature, and this effect was only moderately imp
eded by anti-NGF. The differential dependence on anti-NGF suggests that adr
energic innervation of the DRG after SNL and CCI may reflect regenerative a
nd collateral sprouting, respectively. Pain behaviour was similarly affecte
d: anti-NGF completely prevented CCI-induced thermal hyperalgesia and mecha
noallodynia, but the same treatment only partly relieved these symptoms fol
lowing SNL. These differences emphasize that although CCI and SNL may resul
t in similar behavioural abnormalities, the underlying mechanisms may be go
verned by distinct processes, differentially dependent on peripheral NGF. T
hese mechanistic differences will have to be considered in the development
of appropriate treatment strategies for neuropathic pain produced by differ
ent types of pathology.